Progress in research on the role played by myeloid‐derived suppressor cells in liver diseases

Abstract Myeloid‐derived suppressor cells (MDSCs) refer to a group of immature myeloid with potent immunosuppressive capacity upon activation by pathological conditions. Because their ability, MDSCs have garnered extensive attention in the past few years fields oncology, infection, chronic inflammation and autoimmune diseases. Research on liver diseases has gradually increased, potential therapeutic roles will be further explored. This review presents summary involvement role played diseases, thus identifying targets for treatment providing new directions disease‐related research.